686 related articles for article (PubMed ID: 26980025)
21. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice.
Wagner KU; Krempler A; Triplett AA; Qi Y; George NM; Zhu J; Rui H
Mol Cell Biol; 2004 Jun; 24(12):5510-20. PubMed ID: 15169911
[TBL] [Abstract][Full Text] [Related]
22. Prolactin and the prolactin receptor: new targets of an old hormone.
Harris J; Stanford PM; Oakes SR; Ormandy CJ
Ann Med; 2004; 36(6):414-25. PubMed ID: 15513293
[TBL] [Abstract][Full Text] [Related]
23. Triennial Lactation Symposium: Prolactin: The multifaceted potentiator of mammary growth and function.
Trott JF; Schennink A; Petrie WK; Manjarin R; VanKlompenberg MK; Hovey RC
J Anim Sci; 2012 May; 90(5):1674-86. PubMed ID: 22205663
[TBL] [Abstract][Full Text] [Related]
24. Defining the role of prolactin as an invasion suppressor hormone in breast cancer cells.
Nouhi Z; Chughtai N; Hartley S; Cocolakis E; Lebrun JJ; Ali S
Cancer Res; 2006 Feb; 66(3):1824-32. PubMed ID: 16452244
[TBL] [Abstract][Full Text] [Related]
25. Progesterone receptors (PR) mediate STAT actions: PR and prolactin receptor signaling crosstalk in breast cancer models.
Leehy KA; Truong TH; Mauro LJ; Lange CA
J Steroid Biochem Mol Biol; 2018 Feb; 176():88-93. PubMed ID: 28442393
[TBL] [Abstract][Full Text] [Related]
26. Reevaluation of the proposed autocrine proliferative function of prolactin in breast cancer.
Nitze LM; Galsgaard ED; Din N; Lund VL; Rasmussen BB; Berchtold MW; Christensen L; Panina S
Breast Cancer Res Treat; 2013 Nov; 142(1):31-44. PubMed ID: 24146212
[TBL] [Abstract][Full Text] [Related]
27. Regulation of prolactin receptor levels and activity in breast cancer.
Swaminathan G; Varghese B; Fuchs SY
J Mammary Gland Biol Neoplasia; 2008 Mar; 13(1):81-91. PubMed ID: 18204982
[TBL] [Abstract][Full Text] [Related]
28. Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth.
Liby K; Neltner B; Mohamet L; Menchen L; Ben-Jonathan N
Breast Cancer Res Treat; 2003 May; 79(2):241-52. PubMed ID: 12825859
[TBL] [Abstract][Full Text] [Related]
29. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
Sultan AS; Brim H; Sherif ZA
Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
[TBL] [Abstract][Full Text] [Related]
30. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
31. Effect of Hordei Fructus Germinatus on differential gene expression in the prolactin signaling pathway in the mammary gland of lactating rats.
Zhang Z; Wei Q; Zeng Y; Jia X; Su H; Lin W; Xing N; Bai H; He Y; Wang Q
J Ethnopharmacol; 2021 Mar; 268():113589. PubMed ID: 33217517
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide screen identifies a novel prognostic signature for breast cancer survival.
Mao XY; Lee MJ; Zhu J; Zhu C; Law SM; Snijders AM
Oncotarget; 2017 Feb; 8(8):14003-14016. PubMed ID: 28122328
[TBL] [Abstract][Full Text] [Related]
33. Hypothyroidism decreases JAK/STAT signaling pathway in lactating rat mammary gland.
Campo Verde Arboccó F; Persia FA; Hapon MB; Jahn GA
Mol Cell Endocrinol; 2017 Jul; 450():14-23. PubMed ID: 28390952
[TBL] [Abstract][Full Text] [Related]
34. Association of prolactin and its receptor gene regions with familial breast cancer.
Vaclavicek A; Hemminki K; Bartram CR; Wagner K; Wappenschmidt B; Meindl A; Schmutzler RK; Klaes R; Untch M; Burwinkel B; Försti A
J Clin Endocrinol Metab; 2006 Apr; 91(4):1513-9. PubMed ID: 16434456
[TBL] [Abstract][Full Text] [Related]
35. Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma.
Manhès C; Kayser C; Bertheau P; Kelder B; Kopchick JJ; Kelly PA; Touraine P; Goffin V
J Endocrinol; 2006 Aug; 190(2):271-85. PubMed ID: 16899561
[TBL] [Abstract][Full Text] [Related]
36. Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness.
Kavarthapu R; Dufau ML
Front Endocrinol (Lausanne); 2022; 13():949396. PubMed ID: 36187116
[TBL] [Abstract][Full Text] [Related]
37. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects.
Gallego MI; Binart N; Robinson GW; Okagaki R; Coschigano KT; Perry J; Kopchick JJ; Oka T; Kelly PA; Hennighausen L
Dev Biol; 2001 Jan; 229(1):163-75. PubMed ID: 11133161
[TBL] [Abstract][Full Text] [Related]
38. [Effects of acupuncture combined with
Zhao X; Hou M
Zhongguo Zhen Jiu; 2017 Dec; 37(12):1309-14. PubMed ID: 29354997
[TBL] [Abstract][Full Text] [Related]
39. Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas.
Michel E; Feldmann SK; Kowalewski MP; Bley CR; Boos A; Guscetti F; Reichler IM
BMC Vet Res; 2012 May; 8():72. PubMed ID: 22647582
[TBL] [Abstract][Full Text] [Related]
40. Prolactin and oestrogen synergistically regulate gene expression and proliferation of breast cancer cells.
Rasmussen LM; Frederiksen KS; Din N; Galsgaard E; Christensen L; Berchtold MW; Panina S
Endocr Relat Cancer; 2010 Sep; 17(3):809-22. PubMed ID: 20601496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
